A citation-based method for searching scientific literature

Corinna E Weckerle, Beverly S Franek, Jennifer A Kelly, Marissa Kumabe, Rachel A Mikolaitis, Stephanie L Green, Tammy O Utset, Meenakshi Jolly, Judith A James, John B Harley, Timothy B Niewold. Arthritis Rheum 2011
Times Cited: 136







List of co-cited articles
964 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
Emily C Baechler, Franak M Batliwalla, George Karypis, Patrick M Gaffney, Ward A Ortmann, Karl J Espe, Katherine B Shark, William J Grande, Karis M Hughes, Vivek Kapur,[...]. Proc Natl Acad Sci U S A 2003
44

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kyriakos A Kirou, Christina Lee, Sandhya George, Kyriakos Louca, Margaret G E Peterson, Mary K Crow. Arthritis Rheum 2005
432
38

High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.
T B Niewold, J Hua, T J A Lehman, J B Harley, M K Crow. Genes Immun 2007
268
36

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
Lynda Bennett, A Karolina Palucka, Edsel Arce, Victoria Cantrell, Josef Borvak, Jacques Banchereau, Virginia Pascual. J Exp Med 2003
30



Immune interferon in the circulation of patients with autoimmune disease.
J J Hooks, H M Moutsopoulos, S A Geis, N I Stahl, J L Decker, A L Notkins. N Engl J Med 1979
606
19

Type I interferon correlates with serological and clinical manifestations of SLE.
M C Dall'era, P M Cardarelli, B T Preston, A Witte, J C Davis. Ann Rheum Dis 2005
178
19

The 1982 revised criteria for the classification of systemic lupus erythematosus.
E M Tan, A S Cohen, J F Fries, A T Masi, D J McShane, N F Rothfield, J G Schaller, N Talal, R J Winchester. Arthritis Rheum 1982
18

IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Timothy B Niewold, Jennifer A Kelly, Silvia N Kariuki, Beverly S Franek, Akaash A Kumar, Kenneth M Kaufman, Kenaz Thomas, Daniel Walker, Stan Kamp, Jacqueline M Frost,[...]. Ann Rheum Dis 2012
90
18

Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.
M Petri, S Singh, H Tesfasyone, R Dedrick, K Fry, Pg Lal, G Williams, Jw Bauer, Pk Gregersen, Tw Behrens,[...]. Lupus 2009
120
17

Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
Timothy B Niewold, Jennifer A Kelly, Marie H Flesch, Luis R Espinoza, John B Harley, Mary K Crow. Arthritis Rheum 2008
202
17


Interferon alpha as a primary pathogenic factor in human lupus.
Timothy B Niewold. J Interferon Cytokine Res 2011
90
17

Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
Melissa R Arbuckle, Micah T McClain, Mark V Rubertone, R Hal Scofield, Gregory J Dennis, Judith A James, John B Harley. N Engl J Med 2003
16

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
336
16

Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.
Silvia N Kariuki, Beverly S Franek, Akaash A Kumar, Jasmine Arrington, Rachel A Mikolaitis, Tammy O Utset, Meenakshi Jolly, Mary K Crow, Andrew D Skol, Timothy B Niewold. Arthritis Res Ther 2010
71
21

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T Merrill, W Winn Chatham,[...]. Arthritis Rheum 2011
720
15

Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
Kyriakos A Kirou, Christina Lee, Sandhya George, Kyriakos Louca, Ioannis G Papagiannis, Margaret G E Peterson, Ngoc Ly, Robert N Woodward, Kirk E Fry, Anna Yin-Har Lau,[...]. Arthritis Rheum 2004
265
15


Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.
John B Harley, Marta E Alarcón-Riquelme, Lindsey A Criswell, Chaim O Jacob, Robert P Kimberly, Kathy L Moser, Betty P Tsao, Timothy J Vyse, Carl D Langefeld, Swapan K Nath,[...]. Nat Genet 2008
896
14

Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
Melissa E Munroe, Rufei Lu, Yan D Zhao, Dustin A Fife, Julie M Robertson, Joel M Guthridge, Timothy B Niewold, George C Tsokos, Michael P Keith, John B Harley,[...]. Ann Rheum Dis 2016
92
15

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.
P Blanco, A K Palucka, M Gill, V Pascual, J Banchereau. Science 2001
876
13

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Xuebing Feng, Hui Wu, Jennifer M Grossman, Punchong Hanvivadhanakul, John D FitzGerald, Grace S Park, Xin Dong, Weiling Chen, Michelle H Kim, Haoling H Weng,[...]. Arthritis Rheum 2006
257
13

Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.
C Landolt-Marticorena, G Bonventi, A Lubovich, C Ferguson, T Unnithan, J Su, D D Gladman, M Urowitz, P R Fortin, J Wither. Ann Rheum Dis 2009
109
13

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
917
13

Genetics of the type I interferon pathway in systemic lupus erythematosus.
Yogita Ghodke-Puranik, Timothy B Niewold. Int J Clin Rheumtol 2013
27
48

Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.
S N Kariuki, Y Ghodke-Puranik, J M Dorschner, B S Chrabot, J A Kelly, B P Tsao, R P Kimberly, M E Alarcón-Riquelme, C O Jacob, L A Criswell,[...]. Genes Immun 2015
39
33

A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, Jacqueline M McBride, Michael J Townsend, Xiaohui Wei, John C Davis, William P Kennedy. Ann Rheum Dis 2016
191
13

Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.
Laurent Chiche, Noémie Jourde-Chiche, Elizabeth Whalen, Scott Presnell, Vivian Gersuk, Kristen Dang, Esperanza Anguiano, Charlie Quinn, Stéphane Burtey, Yvon Berland,[...]. Arthritis Rheumatol 2014
164
13

Age- and sex-related patterns of serum interferon-alpha activity in lupus families.
Timothy B Niewold, Jeremy E Adler, Stuart B Glenn, Thomas J A Lehman, John B Harley, Mary K Crow. Arthritis Rheum 2008
59
20

Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
Rafah Salloum, Beverly S Franek, Silvia N Kariuki, Lesley Rhee, Rachel A Mikolaitis, Meenakshi Jolly, Tammy O Utset, Timothy B Niewold. Arthritis Rheum 2010
100
12


Systemic lupus erythematosus.
George C Tsokos. N Engl J Med 2011
12

Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.
Talin Robinson, Silvia N Kariuki, Beverly S Franek, Marissa Kumabe, Akaash A Kumar, Maria Badaracco, Rachel A Mikolaitis, Galen Guerrero, Tammy O Utset, Barbara E Drevlow,[...]. J Immunol 2011
97
11

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Joan T Merrill, Daniel J Wallace, Michelle Petri, Kyriakos A Kirou, Yihong Yao, Wendy I White, Gabriel Robbie, Robert Levin, Seth M Berney, Vishala Chindalore,[...]. Ann Rheum Dis 2011
166
11

Systemic lupus erythematosus disease activity index 2000.
Dafna D Gladman, Dominique Ibañez, Murray B Urowitz. J Rheumatol 2002
11


Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.
Silvia N Kariuki, Kyriakos A Kirou, Emma J MacDermott, Lilliana Barillas-Arias, Mary K Crow, Timothy B Niewold. J Immunol 2009
156
11


Serum interferon levels in patients with systemic lupus erythematosus.
S R Ytterberg, T J Schnitzer. Arthritis Rheum 1982
253
11

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Munther Khamashta, Joan T Merrill, Victoria P Werth, Richard Furie, Kenneth Kalunian, Gabor G Illei, Jorn Drappa, Liangwei Wang, Warren Greth. Ann Rheum Dis 2016
246
11

Type I interferon in rheumatic diseases.
Theresa L Wampler Muskardin, Timothy B Niewold. Nat Rev Rheumatol 2018
75
14

Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus.
Kichul Ko, Beverly S Franek, Miranda Marion, Kenneth M Kaufman, Carl D Langefeld, John B Harley, Timothy B Niewold. J Rheumatol 2012
23
43

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yihong Yao, Laura Richman, Brandon W Higgs, Christopher A Morehouse, Melissa de los Reyes, Philip Brohawn, Jianliang Zhang, Barbara White, Anthony J Coyle, Peter A Kiener,[...]. Arthritis Rheum 2009
200
10

B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.
Lauren L Ritterhouse, Sherry R Crowe, Timothy B Niewold, Joan T Merrill, Virginia C Roberts, Amy B Dedeke, Barbara R Neas, Linda F Thompson, Joel M Guthridge, Judith A James. Arthritis Rheum 2011
41
24

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
Robert R Graham, Sergey V Kozyrev, Emily C Baechler, M V Prasad Linga Reddy, Robert M Plenge, Jason W Bauer, Ward A Ortmann, Thearith Koeuth, Ma Francisca González Escribano, Bernardo Pons-Estel,[...]. Nat Genet 2006
455
10



A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.
Vesela Gateva, Johanna K Sandling, Geoff Hom, Kimberly E Taylor, Sharon A Chung, Xin Sun, Ward Ortmann, Roman Kosoy, Ricardo C Ferreira, Gunnel Nordmark,[...]. Nat Genet 2009
562
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.